Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

NCT01649258 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped Lack of Efficacy

Conditions

Breast Cancer
Nausea
Vomiting

Interventions

DRUG: granisetron transdermal system
DRUG: fosaprepitant dimeglumine
OTHER: laboratory biomarker analysis

Sponsor

University of Southern California

Collaborators

[object Object]